BlackRock Group’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$265K Buy
4,976
+275
+6% +$15.6K ﹤0.01% 2578
2016
Q3
$286K Buy
4,701
+117
+3% +$7.29K ﹤0.01% 2502
2016
Q2
$302K Sell
4,584
-563
-11% -$35.7K ﹤0.01% 2435
2016
Q1
$292K Buy
5,147
+215
+4% +$24.2K ﹤0.01% 2447
2015
Q4
$1.16M Sell
4,932
-473
-9% -$103K ﹤0.01% 1800
2015
Q3
$854K Buy
5,405
+994
+23% +$281K ﹤0.01% 1975
2015
Q2
$1.67M Buy
4,411
+980
+29% +$389K ﹤0.01% 1654
2015
Q1
$1.43M Buy
3,431
+959
+39% +$343K ﹤0.01% 1655
2014
Q4
$677K Buy
2,472
+92
+4% +$22.9K ﹤0.01% 2106
2014
Q3
$463K Sell
2,380
-27
-1% -$5.88K ﹤0.01% 2199
2014
Q2
$589K Sell
2,407
-1,362
-36% -$308K ﹤0.01% 2134
2014
Q1
$999K Buy
3,769
+1,304
+53% +$499K ﹤0.01% 1985
2013
Q4
$896K Sell
2,465
-17,600
-88% -$6.78M ﹤0.01% 2017
2013
Q3
$10.7M Sell
20,065
-4,305
-18% -$1.48M 0.01% 913
2013
Q2
$5.71M Buy
+24,370
New +$4.8M ﹤0.01% 962

Other funds holding CLDX